Loading…
Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy
Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood. We evaluated changes in QoL from baseline to 9-month follow-up using the EQ-5D questionnaire in patients enrolled in the Multice...
Saved in:
Published in: | The American heart journal 2017-07, Vol.189, p.75-84 |
---|---|
Main Authors: | , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953 |
---|---|
cites | cdi_FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953 |
container_end_page | 84 |
container_issue | |
container_start_page | 75 |
container_title | The American heart journal |
container_volume | 189 |
creator | Perini, Alessandro Paoletti Kutyifa, Valentina Veazie, Peter Daubert, James P. Schuger, Claudio Zareba, Wojciech McNitt, Scott Rosero, Spencer Tompkins, Christine Padeletti, Luigi Moss, Arthur J. |
description | Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood.
We evaluated changes in QoL from baseline to 9-month follow-up using the EQ-5D questionnaire in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial—Reduce Inappropriate Therapy (MADIT-RIT) (n=1,268). We assessed anxiety levels using the Florida Shock Anxiety Scale (1-10 score) in patients with appropriate or inappropriate shocks or ATP compared to those with no ICD therapy during the first 9 months postimplant. The analysis was stratified by number of ATP or shocks (0-1 vs ≥2) and adjusted for covariates.
In MADIT-RIT, 15 patients (1%) had ≥2 appropriate shocks, 38 (3%) had ≥2 appropriate ATPs. Two or more inappropriate shocks were delivered in 16 patients (1%); ≥2 inappropriate ATPs, in 70. In multivariable analysis, patients with ≥2 appropriate shocks had higher levels of shock-related anxiety than those with ≤1 appropriate shock (P .05).
In MADIT-RIT, ≥2 appropriate or inappropriate ICD shocks and ≥2 appropriate ATPs are associated with more anxiety at 9-month follow-up despite no significant changes in the assessment of global QoL by the EQ-5D questionnaire. Innovative ICD programming reducing inappropriate therapies may help deal with patient concerns about the device. |
doi_str_mv | 10.1016/j.ahj.2017.03.009 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1911199480</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0002870317300923</els_id><sourcerecordid>1922855920</sourcerecordid><originalsourceid>FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953</originalsourceid><addsrcrecordid>eNp9kc1u1DAQgC0EotvCA3BBlrhwSWonjp3AadUfWKkVElrOlmOPWYdsvLWdin2CvjbebuHAoYexx_I3458PoXeUlJRQfj6UajOUFaGiJHVJSPcCLSjpRMEFYy_RghBSFa0g9Qk6jXHIS161_DU6yWPV1C1boIcra0GniL3Fbrsb1ZRUPwLWKhjn7yEkCOcGrOuDG0eVfMBx4_UvrCaTI7mk9Gb_SCu8U9pNP7Gf8s5vB2n_SN3NanQ5zyeMzsInvMS3y8vVuvi-WuM49zHNZv8GvbJqjPD2aT5DP66v1hdfi5tvX1YXy5tCMyZSQa3pSUs11cpW0LIaGK9FDm4aBn3Td7atCaeUc8ZAMAqEE8sqK6gQddfUZ-jjse8u-LsZYpJbFzXkp03g5yhpRyntOtaSjH74Dx38HKZ8u0xVVds0XXWg6JHSwccYwMpdcFsV9pISebAkB5ktyYMlSWqZLeWa90-d534L5l_FXy0Z-HwEIH_FvYMgo3YwaTAuZFvSePdM-z_RNKHm</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1922855920</pqid></control><display><type>article</type><title>Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Perini, Alessandro Paoletti ; Kutyifa, Valentina ; Veazie, Peter ; Daubert, James P. ; Schuger, Claudio ; Zareba, Wojciech ; McNitt, Scott ; Rosero, Spencer ; Tompkins, Christine ; Padeletti, Luigi ; Moss, Arthur J.</creator><creatorcontrib>Perini, Alessandro Paoletti ; Kutyifa, Valentina ; Veazie, Peter ; Daubert, James P. ; Schuger, Claudio ; Zareba, Wojciech ; McNitt, Scott ; Rosero, Spencer ; Tompkins, Christine ; Padeletti, Luigi ; Moss, Arthur J.</creatorcontrib><description>Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood.
We evaluated changes in QoL from baseline to 9-month follow-up using the EQ-5D questionnaire in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial—Reduce Inappropriate Therapy (MADIT-RIT) (n=1,268). We assessed anxiety levels using the Florida Shock Anxiety Scale (1-10 score) in patients with appropriate or inappropriate shocks or ATP compared to those with no ICD therapy during the first 9 months postimplant. The analysis was stratified by number of ATP or shocks (0-1 vs ≥2) and adjusted for covariates.
In MADIT-RIT, 15 patients (1%) had ≥2 appropriate shocks, 38 (3%) had ≥2 appropriate ATPs. Two or more inappropriate shocks were delivered in 16 patients (1%); ≥2 inappropriate ATPs, in 70. In multivariable analysis, patients with ≥2 appropriate shocks had higher levels of shock-related anxiety than those with ≤1 appropriate shock (P<.01). Furthermore, ≥2 inappropriate shocks produced more anxiety than ≤1 inappropriate shock (P=.005). Consistently, ≥2 appropriate ATPs resulted in more anxiety than ≤1 (P=.028), whereas the number of inappropriate ATPs showed no association with anxiety levels (P=.997). However, there was no association between QoL and appropriate or inappropriate ATP/shock (all P values > .05).
In MADIT-RIT, ≥2 appropriate or inappropriate ICD shocks and ≥2 appropriate ATPs are associated with more anxiety at 9-month follow-up despite no significant changes in the assessment of global QoL by the EQ-5D questionnaire. Innovative ICD programming reducing inappropriate therapies may help deal with patient concerns about the device.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2017.03.009</identifier><identifier>PMID: 28625384</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Anxiety ; Anxiety - etiology ; Anxiety - psychology ; Cardiac arrhythmia ; Councils ; Defibrillators ; Defibrillators, Implantable ; Electric Countershock - instrumentation ; Female ; Follow-Up Studies ; Heart attacks ; Heart failure ; Humans ; Implantation ; Male ; Middle Aged ; Mortality ; Patients ; Quality of Life ; Questionnaires ; Risk Factors ; Shock ; Surveys and Questionnaires ; Tachycardia, Ventricular - complications ; Tachycardia, Ventricular - psychology ; Tachycardia, Ventricular - therapy ; Therapy ; Time Factors ; Transplants & implants ; Treatment Outcome ; Women</subject><ispartof>The American heart journal, 2017-07, Vol.189, p.75-84</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Jul 1, 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953</citedby><cites>FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28625384$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Perini, Alessandro Paoletti</creatorcontrib><creatorcontrib>Kutyifa, Valentina</creatorcontrib><creatorcontrib>Veazie, Peter</creatorcontrib><creatorcontrib>Daubert, James P.</creatorcontrib><creatorcontrib>Schuger, Claudio</creatorcontrib><creatorcontrib>Zareba, Wojciech</creatorcontrib><creatorcontrib>McNitt, Scott</creatorcontrib><creatorcontrib>Rosero, Spencer</creatorcontrib><creatorcontrib>Tompkins, Christine</creatorcontrib><creatorcontrib>Padeletti, Luigi</creatorcontrib><creatorcontrib>Moss, Arthur J.</creatorcontrib><title>Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood.
We evaluated changes in QoL from baseline to 9-month follow-up using the EQ-5D questionnaire in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial—Reduce Inappropriate Therapy (MADIT-RIT) (n=1,268). We assessed anxiety levels using the Florida Shock Anxiety Scale (1-10 score) in patients with appropriate or inappropriate shocks or ATP compared to those with no ICD therapy during the first 9 months postimplant. The analysis was stratified by number of ATP or shocks (0-1 vs ≥2) and adjusted for covariates.
In MADIT-RIT, 15 patients (1%) had ≥2 appropriate shocks, 38 (3%) had ≥2 appropriate ATPs. Two or more inappropriate shocks were delivered in 16 patients (1%); ≥2 inappropriate ATPs, in 70. In multivariable analysis, patients with ≥2 appropriate shocks had higher levels of shock-related anxiety than those with ≤1 appropriate shock (P<.01). Furthermore, ≥2 inappropriate shocks produced more anxiety than ≤1 inappropriate shock (P=.005). Consistently, ≥2 appropriate ATPs resulted in more anxiety than ≤1 (P=.028), whereas the number of inappropriate ATPs showed no association with anxiety levels (P=.997). However, there was no association between QoL and appropriate or inappropriate ATP/shock (all P values > .05).
In MADIT-RIT, ≥2 appropriate or inappropriate ICD shocks and ≥2 appropriate ATPs are associated with more anxiety at 9-month follow-up despite no significant changes in the assessment of global QoL by the EQ-5D questionnaire. Innovative ICD programming reducing inappropriate therapies may help deal with patient concerns about the device.</description><subject>Anxiety</subject><subject>Anxiety - etiology</subject><subject>Anxiety - psychology</subject><subject>Cardiac arrhythmia</subject><subject>Councils</subject><subject>Defibrillators</subject><subject>Defibrillators, Implantable</subject><subject>Electric Countershock - instrumentation</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Heart attacks</subject><subject>Heart failure</subject><subject>Humans</subject><subject>Implantation</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Patients</subject><subject>Quality of Life</subject><subject>Questionnaires</subject><subject>Risk Factors</subject><subject>Shock</subject><subject>Surveys and Questionnaires</subject><subject>Tachycardia, Ventricular - complications</subject><subject>Tachycardia, Ventricular - psychology</subject><subject>Tachycardia, Ventricular - therapy</subject><subject>Therapy</subject><subject>Time Factors</subject><subject>Transplants & implants</subject><subject>Treatment Outcome</subject><subject>Women</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kc1u1DAQgC0EotvCA3BBlrhwSWonjp3AadUfWKkVElrOlmOPWYdsvLWdin2CvjbebuHAoYexx_I3458PoXeUlJRQfj6UajOUFaGiJHVJSPcCLSjpRMEFYy_RghBSFa0g9Qk6jXHIS161_DU6yWPV1C1boIcra0GniL3Fbrsb1ZRUPwLWKhjn7yEkCOcGrOuDG0eVfMBx4_UvrCaTI7mk9Gb_SCu8U9pNP7Gf8s5vB2n_SN3NanQ5zyeMzsInvMS3y8vVuvi-WuM49zHNZv8GvbJqjPD2aT5DP66v1hdfi5tvX1YXy5tCMyZSQa3pSUs11cpW0LIaGK9FDm4aBn3Td7atCaeUc8ZAMAqEE8sqK6gQddfUZ-jjse8u-LsZYpJbFzXkp03g5yhpRyntOtaSjH74Dx38HKZ8u0xVVds0XXWg6JHSwccYwMpdcFsV9pISebAkB5ktyYMlSWqZLeWa90-d534L5l_FXy0Z-HwEIH_FvYMgo3YwaTAuZFvSePdM-z_RNKHm</recordid><startdate>201707</startdate><enddate>201707</enddate><creator>Perini, Alessandro Paoletti</creator><creator>Kutyifa, Valentina</creator><creator>Veazie, Peter</creator><creator>Daubert, James P.</creator><creator>Schuger, Claudio</creator><creator>Zareba, Wojciech</creator><creator>McNitt, Scott</creator><creator>Rosero, Spencer</creator><creator>Tompkins, Christine</creator><creator>Padeletti, Luigi</creator><creator>Moss, Arthur J.</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>201707</creationdate><title>Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy</title><author>Perini, Alessandro Paoletti ; Kutyifa, Valentina ; Veazie, Peter ; Daubert, James P. ; Schuger, Claudio ; Zareba, Wojciech ; McNitt, Scott ; Rosero, Spencer ; Tompkins, Christine ; Padeletti, Luigi ; Moss, Arthur J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Anxiety</topic><topic>Anxiety - etiology</topic><topic>Anxiety - psychology</topic><topic>Cardiac arrhythmia</topic><topic>Councils</topic><topic>Defibrillators</topic><topic>Defibrillators, Implantable</topic><topic>Electric Countershock - instrumentation</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Heart attacks</topic><topic>Heart failure</topic><topic>Humans</topic><topic>Implantation</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Patients</topic><topic>Quality of Life</topic><topic>Questionnaires</topic><topic>Risk Factors</topic><topic>Shock</topic><topic>Surveys and Questionnaires</topic><topic>Tachycardia, Ventricular - complications</topic><topic>Tachycardia, Ventricular - psychology</topic><topic>Tachycardia, Ventricular - therapy</topic><topic>Therapy</topic><topic>Time Factors</topic><topic>Transplants & implants</topic><topic>Treatment Outcome</topic><topic>Women</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Perini, Alessandro Paoletti</creatorcontrib><creatorcontrib>Kutyifa, Valentina</creatorcontrib><creatorcontrib>Veazie, Peter</creatorcontrib><creatorcontrib>Daubert, James P.</creatorcontrib><creatorcontrib>Schuger, Claudio</creatorcontrib><creatorcontrib>Zareba, Wojciech</creatorcontrib><creatorcontrib>McNitt, Scott</creatorcontrib><creatorcontrib>Rosero, Spencer</creatorcontrib><creatorcontrib>Tompkins, Christine</creatorcontrib><creatorcontrib>Padeletti, Luigi</creatorcontrib><creatorcontrib>Moss, Arthur J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>PML(ProQuest Medical Library)</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Perini, Alessandro Paoletti</au><au>Kutyifa, Valentina</au><au>Veazie, Peter</au><au>Daubert, James P.</au><au>Schuger, Claudio</au><au>Zareba, Wojciech</au><au>McNitt, Scott</au><au>Rosero, Spencer</au><au>Tompkins, Christine</au><au>Padeletti, Luigi</au><au>Moss, Arthur J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2017-07</date><risdate>2017</risdate><volume>189</volume><spage>75</spage><epage>84</epage><pages>75-84</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><abstract>Effects of implantable cardioverter/defibrillator (ICD) shocks and antitachycardia pacing (ATP) on anxiety and quality of life (QoL) in ICD patients are poorly understood.
We evaluated changes in QoL from baseline to 9-month follow-up using the EQ-5D questionnaire in patients enrolled in the Multicenter Automatic Defibrillator Implantation Trial—Reduce Inappropriate Therapy (MADIT-RIT) (n=1,268). We assessed anxiety levels using the Florida Shock Anxiety Scale (1-10 score) in patients with appropriate or inappropriate shocks or ATP compared to those with no ICD therapy during the first 9 months postimplant. The analysis was stratified by number of ATP or shocks (0-1 vs ≥2) and adjusted for covariates.
In MADIT-RIT, 15 patients (1%) had ≥2 appropriate shocks, 38 (3%) had ≥2 appropriate ATPs. Two or more inappropriate shocks were delivered in 16 patients (1%); ≥2 inappropriate ATPs, in 70. In multivariable analysis, patients with ≥2 appropriate shocks had higher levels of shock-related anxiety than those with ≤1 appropriate shock (P<.01). Furthermore, ≥2 inappropriate shocks produced more anxiety than ≤1 inappropriate shock (P=.005). Consistently, ≥2 appropriate ATPs resulted in more anxiety than ≤1 (P=.028), whereas the number of inappropriate ATPs showed no association with anxiety levels (P=.997). However, there was no association between QoL and appropriate or inappropriate ATP/shock (all P values > .05).
In MADIT-RIT, ≥2 appropriate or inappropriate ICD shocks and ≥2 appropriate ATPs are associated with more anxiety at 9-month follow-up despite no significant changes in the assessment of global QoL by the EQ-5D questionnaire. Innovative ICD programming reducing inappropriate therapies may help deal with patient concerns about the device.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28625384</pmid><doi>10.1016/j.ahj.2017.03.009</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-8703 |
ispartof | The American heart journal, 2017-07, Vol.189, p.75-84 |
issn | 0002-8703 1097-6744 |
language | eng |
recordid | cdi_proquest_miscellaneous_1911199480 |
source | ScienceDirect Freedom Collection 2022-2024 |
subjects | Anxiety Anxiety - etiology Anxiety - psychology Cardiac arrhythmia Councils Defibrillators Defibrillators, Implantable Electric Countershock - instrumentation Female Follow-Up Studies Heart attacks Heart failure Humans Implantation Male Middle Aged Mortality Patients Quality of Life Questionnaires Risk Factors Shock Surveys and Questionnaires Tachycardia, Ventricular - complications Tachycardia, Ventricular - psychology Tachycardia, Ventricular - therapy Therapy Time Factors Transplants & implants Treatment Outcome Women |
title | Effects of implantable cardioverter/defibrillator shock and antitachycardia pacing on anxiety and quality of life: A MADIT-RIT substudy |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T20%3A48%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20implantable%20cardioverter/defibrillator%20shock%20and%20antitachycardia%20pacing%20on%20anxiety%20and%20quality%20of%20life:%20A%20MADIT-RIT%20substudy&rft.jtitle=The%20American%20heart%20journal&rft.au=Perini,%20Alessandro%20Paoletti&rft.date=2017-07&rft.volume=189&rft.spage=75&rft.epage=84&rft.pages=75-84&rft.issn=0002-8703&rft.eissn=1097-6744&rft_id=info:doi/10.1016/j.ahj.2017.03.009&rft_dat=%3Cproquest_cross%3E1922855920%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c447t-1fdb081c1caf2e843e46374636d54eb5b9f8306116644e741e060f42f71773953%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1922855920&rft_id=info:pmid/28625384&rfr_iscdi=true |